Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monoclonal Antibodies for Prevention and Treatment of COVID-19.

× No keyword cloud information.

80 in total

1. SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.

Authors: Aileen X Wang; Stephan Busque; Jamie Kuo; Upinder Singh; Katharina Röeltgen; Benjamin A Pinsky; Glenn M Chertow; John D Scandling; Colin R Lenihan
Journal: Kidney360 Date: 2021-10-20

2. Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.

Authors: Anita M Trichel
Journal: Comp Med Date: 2021-09-21 Impact factor: 0.982

3. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases.

Authors: Aishwarya Mary Johnson; Robert Barigye; Hariharan Saminathan
Journal: Hum Vaccin Immunother Date: 2021-05-11 Impact factor: 3.452

4. A glimmer of hope for the most vulnerable.

Authors: Ann R Falsey
Journal: J Am Geriatr Soc Date: 2021-05-24 Impact factor: 7.538

5. Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.

Authors: Ayan Dey; T M Chozhavel Rajanathan; Harish Chandra; Hari P R Pericherla; Sanjeev Kumar; Huzaifa S Choonia; Mayank Bajpai; Arun K Singh; Anuradha Sinha; Gurwinder Saini; Parth Dalal; Sarosh Vandriwala; Mohammed A Raheem; Rupesh D Divate; Neelam L Navlani; Vibhuti Sharma; Aashini Parikh; Siva Prasath; M Sankar Rao; Kapil Maithal
Journal: Vaccine Date: 2021-06-01 Impact factor: 4.169

Review 6. Commentary: Convalescent plasma to treat COVID-19: Following the Argentinian lead.

Authors: Pierre Tiberghien; Eric Toussirot; Pascale Richard; Pascal Morel; Olivier Garraud
Journal: Transfus Apher Sci Date: 2021-05-23 Impact factor: 1.764

7. A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.

Authors: Kaleb B Tsegay; Christiana M Adeyemi; Edward P Gniffke; D Noah Sather; John K Walker; Stephen E P Smith
Journal: Front Pharmacol Date: 2021-06-14 Impact factor: 5.810

Review 8. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors: Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal: Front Immunol Date: 2021-06-30 Impact factor: 7.561

Review 9. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.

Authors: Shamus P Keeler; Julie M Fox
Journal: Viruses Date: 2021-05-31 Impact factor: 5.048

10. Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center.

Authors: Poonam Kumari; Amarjeet Kumar; Chandni Sinha; Ajeet Kumar; Prabhat K Singh; S K Arun
Journal: Indian J Crit Care Med Date: 2021-04